5. Volumes in Ion-Beam Therapy

Albertini F. , Hug E.B. , and Lomax A.J. (2011). “Is it necessary to plan with safety margins for actively scanned proton therapy?,” Phys. Med. Biol. 56, 4399.

Amin M.B. , Greene F.L. , Edge S.B. , Compton C.C. , Gershenwald J.E. , Brookland R.K. , Meyer L. , Gress D.M. , Byrd D.R. , and Winchester D.P. (2017). “The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population‐based to a more ‘personalized’ approach to cancer staging,” CA Cancer J. Clin. 67, 93–99.

Baum C. , Alber M. , Birkner M. , and Nusslin F. (2006). “Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities,” Radiother. Oncol. 78, 27–35.

Beadle B.M. , Jhingran A. , Salehpour M. , Sam M. , Iyer R.B. , and Eifel P.J. (2009). “Cervix regression and motion during the course of external beam chemoradiation for cervical cancer,” Int. J. Radiat. Oncol. 73, 235–241.

Bortfeld T. , Jokivarsi K. , Goitein M. , Kung J. , and Jiang S.B. (2002). “Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation,” Phys. Med. Biol. 47, 2203–2220.

Brevet R. , Richter D. , Graeff C. , Durante M. , and Bert C. (2015). “Treatment parameters optimization to compensate for interfractional anatomy variability and intrafractional tumor motion,” Front. Oncol. 5, 291.

Brierley J.D. , Gospodarowicz M.K. , and Wittekind C. (2016). TNM Classification of Malignant Tumours. (John Wiley & Sons).

Differding S. , Hanin F.X. , and Gregoire V. (2015). “PET imaging biomarkers in head and neck cancer,” Eur. J. Nucl. Med. Mol. Imaging 42, 613–622.

Dong Y. , Guan H. , Huang W. , Zhang Z. , Zhao D. , Liu Y. , Zhou T. , and Li B. (2015). “Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases,” J. Thorac. Dis. 7, 2313–2320.

Eley J.G. , Newhauser W.D. , Richter D. , Luchtenborg R. , Saito N. , and Bert C. (2015). “Robustness of target dose coverage to motion uncertainties for scanned carbon ion beam tracking therapy of moving tumors,” Phys. Med. Biol. 60, 1717–1740.

Fredriksson A. , Forsgren A. , and Hardemark B. (2015). “Maximizing the probability of satisfying the clinical goals in radiation therapy treatment planning under setup uncertainty,” Med. Phys. 42, 3992–3999.

Fritz A. , Percy C. , Jack A. , Shanmugaratnam K. , Sobin L. , Parkin D.M. , and Whelan S. (2013). International Classification of Diseases for Oncology. 3rd ed., 1st Rev (World Health Organization).

Geets X. , Daisne J.F. , Tomsej M. , Duprez T. , Lonneux M. , and Gregoire V. (2006). “Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies,” Radiother. Oncol. 78, 291–297.

Geets X. , Tomsej M. , Lee J.A. , Duprez T. , Coche E. , Cosnard G. , Lonneux M. , and Gregoire V. (2007). “Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: Impact on target volume delineation and dose distribution using helical tomotherapy,” Radiother. Oncol. 85, 105–115.

Ghadjar P. , Schreiber-Facklam H. , Grater R. , Evers C. , Simcock M. , Geretschlager A. , Blumstein N.M. , Zbaren P. , Zimmer Y. , Wilkens L. , and Aebersold D.M. (2010). “Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma,” Int. J. Radiat. Oncol. Biol. Phys. 76, 1127–1132.

Grégoire V. , Ang K. , Budach W. , Grau C. , Hamoir M. , Langendijk J.A. , Lee A. , Le Q.T. , Maingon P. , Nutting C. , O'Sullivan B. , Porceddu S.V. , and Lengele B. (2014). “Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines,” Radiother. Oncol. 110, 172–181.

Grégoire V. , Coche E. , Cosnard G. , Hamoir M. , and Reychler H. (2000). “Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience,” Radiother. Oncol. 56, 135–150.

Grégoire V. , Jeraj R. , Lee J.A. , and O'Sullivan B. (2012). “Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?,” Lancet Oncol. 13, e292–e300.

Grégoire V. , Scalliet P. , and Ang K. (2004). Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy: a clinical guide to cancer treatment. (Springer, Berlin, Heidelberg).

Harris V.A. , Staffurth J. , Naismith O. , Esmail A. , Gulliford S. , Khoo V. , Lewis R. , Littler J. , McNair H. , Sadoyze A. , Scrase C. , Sohaib A. , Syndikus I. , Zarkar A. , Hall E. , Dearnaley D. , and Trialists P. (2015). “Consensus guidelines and contouring atlas for pelvic node delineation in prostate and pelvic node intensity modulated radiation therapy,” Int. J. Radiat. Oncol. Biol. Phys. 92, 874–883.

Hockel M. , Horn L.C. , Tetsch E. , and Einenkel J. (2012). “Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy,” Gynecol. Oncol. 125, 168–174.

ICRU (1993). International Commission on Radiation Units and Measurements, Prescribing, Recording and Reporting Photon Beam Therapy. ICRU Report 50 (International Commission on Radiation Units and Measurements, Bethesda, MD).

ICRU (1999). International Commission on Radiation Units and Measurements, Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). ICRU Report 62 (International Commission on Radiation Units and Measurements, Bethesda, MD).

ICRU (2004). International Commission on Radiation Units and Measurements, Prescribing, Recording, and Reporting Electron Beam Therapy. ICRU Report 71, J. ICRU Vol. 4(1) (Oxford University Press, Oxford).

ICRU (2007). International Commission on Radiation Units and Measurements, Prescribing, Recording, and Reporting Proton-Beam Therapy. ICRU Report 78, J. ICRU Vol. 7(2) (Oxford University Press, Oxford).

ICRU (2010). International Commission on Radiation Units and Measurements, State of the Art on Dose Prescription, Reporting and Recording in Intensity-Modulated Radiation Therapy. ICRU Report 83, J. ICRU Vol. 10(1) (Oxford University Press, Oxford).

Konert T. , Vogel W. , MacManus M.P. , Nestle U. , Belderbos J. , Gregoire V. , Thorwarth D. , Fidarova E. , Paez D. , Chiti A. , and Hanna G.G. (2015). “PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014,” Radiother. Oncol. 116, 27–34.

Langman G. , Patel A. , and Bowley D.M. (2015). “Size and distribution of lymph nodes in rectal cancer resection specimens,” Dis. Colon Rectum 58, 406–414.

Lim K. , Small W. Jr. , Portelance L. , Creutzberg C. , Jurgenliemk-Schulz I.M. , Mundt A. , Mell L.K. , Mayr N. , Viswanathan A. , Jhingran A. , Erickson B. , De los Santos J. , Gaffney D. , Yashar C. , Beriwal S. , Wolfson A. , Taylor A. , Bosch W. , El Naqa I. , Fyles A. , and Gyn I.C. (2011). “Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer,” Int. J. Radiat. Oncol. Biol. Phys. 79, 348–355.

Ling C.C. , Humm J. , Larson S. , Amols H. , Fuks Z. , Leibel S. , and Koutcher J.A. (2000). “Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality,” Int. J. Radiat. Oncol. 47, 551–560.

McGowan S.E. , Albertini F. , Thomas S.J. , and Lomax A.J. (2015). “Defining robustness protocols: a method to include and evaluate robustness in clinical plans,” Phys. Med. Biol. 60, 2671–2684.

McGowan S.E. , Burnet N.G. , and Lomax A.J. (2013). “Treatment planning optimisation in proton therapy,” Br. J. Radiol. 86, 20120288.

Offersen B.V. , Boersma L.J. , Kirkove C. , Hol S. , Aznar M.C. , Sola A.B. , Kirova Y.M. , Pignol J.P. , Remouchamps V. , Verhoeven K. , Weltens C. , Arenas M. , Gabrys D. , Kopek N. , Krause M. , Lundstedt D. , Marinko T. , Montero A. , Yarnold J. , and Poortmans P. (2016). “ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1,” Radiother. Oncol. 118, 205–208.

O'Sullivan B. , Wunder J. , and Pisters P. (2004). “Target description for radiotherapy of soft tissue sarcoma,” pp. 205–227 in Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy – A Clinical Guide to Cancer Treatement, Grégoire V. , Scalliet P. , and Ang K. , Eds. (Springer, Berlin, Heidelberg, New York).

Partin A.W. , Mangold L.A. , Lamm D.M. , Walsh P.C. , Epstein J.I. , and Pearson J.D. (2001). “Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium,” Urology 58, 843–848.

Phillips M.H. , Pedroni E. , Blattmann H. , Boehringer T. , Coray A. , and Scheib S. (1992). “Effects of respiratory motion on dose uniformity with a charged particle scanning method,” Phys. Med. Biol. 37, 223–234.

Roels S. , Duthoy W. , Haustermans K. , Penninckx F. , Vandecaveye V. , Boterberg T. , and De Neve W. (2006). “Definition and delineation of the clinical target volume for rectal cancer,” Int. J. Radiat. Oncol. Biol. Phys. 65, 1129–1142.

Urie M. , Goitein M. , and Wagner M. (1984). “Compensating for heterogeneities in proton radiation therapy,” Phys. Med. Biol. 29, 553–566.

van Herk M. (2004). “Errors and margins in radiotherapy,” Semin. Radiat. Oncol. 14, 52–64.

Vanderstraeten B. , Duthoy W. , De Gersem W. , De Neve W. , and Thierens H. (2006). “[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer,” Radiother. Oncol. 79, 249–258.

Wang D. , Bosch W. , Kirsch D.G. , Al Lozi R. , El Naqa I. , Roberge D. , Finkelstein S.E. , Petersen I. , Haddock M. , Chen Y.L. , Saito N.G. , Hitchcock Y.J. , Wolfson A.H. , and DeLaney T.F. (2011). “Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists,” Int. J. Radiat. Oncol. Biol. Phys. 81, e775–e780.

Weltens C. , Menten J. , Feron M. , Bellon E. , Demaerel P. , Maes F. , Van den Bogaert W. , and van der Schueren E. (2001). “Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging,” Radiother. Oncol. 60, 49–59.

Withers H.R. , Taylor J.M. , and Maciejewski B. (1988). “Treatment volume and tissue tolerance,” Int. J. Radiat. Oncol. Biol. Phys. 14, 751–759.